Clinical stage biopharmaceutical company
Pleco Therapeutics has raised €17M across 1 funding round from 3 investors, most recently a Series A round in Sep 2022. Based in Nijmegen, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-07 | Series A | €17M |
| Hyloris Pharmaceuticals ,Netherlands Enterprise Agency,Oost NL |
| View deal → |
